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ABSTRACT  Rotavirus, a non-enveloped  reovirus, buds into the rough endoplasmic reticulum 
and  transiently  acquires a  membrane. The  structural  glycoprotein,  VP7, a  38-kD  integral 
membrane  protein  of the endoplasmic reticulum  (ER), presumably transfers to vi.rus in this 
process. The gene for VP7 potentially  encodes a protein of 326 amino acids which has two 
tandem hydrophobic domains at the NH2-terminal, each preceded by an in-frame ATG codon. 
A series of deletion mutants constructed  from a full-length  cDNA clone of the Simian 11 
rotavirus VP7 gene were  expressed in COS  7 cells. Products from  wild-type,  and mutants 
which did not affect the second hydrophobic domain of VP7, were localized by immunoflu- 
orescence to elements of the ER only. However, deletions affecting the second hydrophobic 
domain (mutants 42-61, 43-61, 47-61) showed immunofluorescent  localization of.VP7 which 
coincided with  that of wheat  germ agglutinin,  indicating  transport to the Golgi  apparatus. 
Immunoprecipitable  wild-type  protein,  or an altered  protein  lacking the first  hydrophobic 
sequence, remained intracellular and endo-~-N-acetylglucosaminidase H sensitive. In contrast, 
products of mutants 42-61, 43-61, and 47-61  were transported from the ER, and secreted. 
Glycosylation of the secreted molecules was inhibited by tunicamycin,  resistant to endo-~-N- 
acetylglucosaminidase H digestion and therefore of the N-linked  complex type. An unglyco- 
sylated version of VP7 was also secreted. We suggest that the second hydrophobic domain 
contributes to a positive signal for ER location and a membrane anchor function. Secretion of 
the mutant glycoprotein  implies that transport can be constitutive with the destination being 
dictated by an overriding compartmentalization  signal. 
The targeting  and  sorting  of membrane  proteins  to  their 
different subcellular compartments has become a major topic 
of interest in  cell biology and a  problem that has become 
increasingly amenable to manipulation by gene cloning tech- 
niques. Membrane maturing viruses have long been used to 
probe questions of this nature (22) because of the high abun- 
dance of the membrane proteins of interest in infected cells. 
Several laboratories have used the cloned genes of membrane 
glycoproteins, such as influenza hemagglutinin (1 l,  17,  35, 
38), vesicular stomatitis virus G protein (15, 19, 34), Semliki 
forest virus (16, 23), and robs sarcoma virus (45) to probe for 
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the portions of the expressed products that are important in 
determining  their  plasma  membrane  localization.  These 
membrane glycoproteins are characterized by a COOH-ter- 
minal hydrophobic membrane anchoring segment and a cy- 
toplasmic tail. Disruption of  the former has generally resulted 
in complete secretion of  these molecules, which in their native 
state traverse most of the secretory pathway. Alterations of 
the COOH-terminal cytoplasmic tail had diverse effects. Some 
mutant proteins became blocked along the secretory pathway 
and others failed to traverse the pathway at all.  The exact 
nature of the signal for targeting these proteins to the plasma 
2199 membrane was not clear from these studies. Failure of these 
molecules to move along the exocytosis pathway may have 
been due to the alteration of a  positive plasma membrane 
targeting signal or to denaturation of the protein product. 
Rotavirus VP7 is a glycoprotein of particular interest as a 
potential model for the study of protein transport (21). This 
protein associates with viral cores that bud into the lumen of 
the  rough  endoplasmic  reticulum  (RER) j  (1)  from  cyto- 
plasmic structures, called viroplasms. Mature virus remains 
within the lumen of the RER until release by cell lysis. VP7 
is an integral membrane glycoprotein with a lumenal orien- 
tation (21) and is located in the endoplasmic reticulum (ER) 
(10,  32).  The Golgi apparatus is not involved in processing 
the mature form of VPT, a fact confirmed by the presence on 
the molecule of the high-mannose form of carbohydrate (9). 
VP7 therefore constitutes an example of a membrane glyco- 
protein that is targeted to the ER and  is  not subsequently 
directed further along the secretory pathway. The cloning and 
sequencing of the SA 11  VP7  gene revealed the presence of 
two tandem NH2-terminal hydrophobic domains in the pro- 
tein, and the absence of a COOH-terminal hydrophobic do- 
main (7).  Each of the hydrophobic domains is preceded by 
an AUG codon and could ostensibly serve as a signal peptide 
for the translocation of VP7,  depending on which codon is 
read for initiation. However, the specific role of each of these 
codons and  hydrophobic segments in  VP7  synthesis is not 
clear. In studying the function of the hydrophobic domains, 
we constructed a  series of deletions in the VP7 gene.  Three 
mutants were obtained for which the VP7 proteins acquired 
complex  carbohydrate,  as  distinct  from  the  high-mannose 
type exhibited by wild-type VP7, showing that they traversed 
the secretory pathway and reached the Golgi apparatus. These 
proteins were also secreted. A priori, the transport of VP7 to 
more distal locations along the secretory route should require 
either  the  modification  of a  positive  signal  specifying  ER 
location, or alternatively,  the addition  of a  signal  enabling 
vectorial transport to occur. The induction of VP7 secretion 
by  creating various deletions  in  the  protein is  more easily 
explained by the disruption of a positive signal specifying ER 
location. We conclude that there must be a positive signal for 
retention of a protein in the ER. Since wild-type VP7 is naive 
to the secretory pathway, it is also implied that in the absence 
of overriding sorting signals, secretion is constitutive. 
MATERIALS  AND  METHODS 
cDNA  Cloning  and  Construction  of  a  Plasmid for  VP7 
Expression:  Standard molecular cloning techniques were used in this work 
(29). The complete sequence of genomic segment nine of Simian  11  rotavirus 
was obtained  previously  using a  partial  length  cDNA  clone that lacked  5'- 
terminal sequences (7). A full-length clone was isolated using a modified cloning 
strategy (20). This yielded a VP7 clone inserted in the Pst I site of pBR322 
which was confirmed  as full length by terminal  sequence analysis (30). The 
insert  was excised with Pst  I, digested with  nuclease Bal 31  to remove  G:C 
homopolymer  tails, and the blunt-ended molecule was flanked with Xho I sites 
by the addition of phosphorylated  Xho I linkers (P-L Bioehemicals). The VP7 
gene with Xho I termini was then inserted into the unique Xho I site of  pJC 119 
(36) to yield plasmid pJC16 which contained  the rotavirus VP7 sequence in 
the correct orientation  downstream  from the SV40 late promoter,  pJC119 was 
obtained from by Dr. J. Condra,  Division of Virus and Cell Biology Research, 
Merck, Sharp & Dohme Research Laboratories,  West Point,  PA. Sequencing 
Abbreviations used in this paper:  DME, Dulbecco's modified Ea- 
gle's medium; endo-H, endo-~-N-acetylglucosaminidase H; ER,  en- 
doplasmic reticulum; PAS,  protein A-conjugated Sepharose CL4B; 
RER, rough endoplasmic reticulum; R-WGA, wheat germ agglutinin 
conjugated to rhodamine. 
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revealed that pJC 16 nevertheless contained residual homopolymeric sequences 
(15G residues) at the 5'-end of the gene. These were removed by replacing the 
5'-terminal  region of the clone proximal to the Nco I site with a fragment that 
lacked  the  residual  homopolymeric  tail. An  Aha  llI-Nco  I  fragment  was 
prepared from the SAIl VP7 clone, Xho I linkers were added to the Aha III 
end, and after recutting, the Xho l-Nco I fragment was cloned into the SV40 
vector to generate the plasmid pJC9 (Fig. 1). 
Preparation of Deletion  Mutants  of VP7:  pJC9  was cut with 
Bam HI and the  387-bp 5'-terminal  fragment  of the VP7 gene (Fig.  1) was 
subcloned into the Barn HI site of pBR322 to generate pBR9B (Fig. 1) which 
contains a unique Nco I site. The plasmid was made linear by cutting with Nco 
I and digested with Bal 31  to remove nucleotides progressively. The products 
were made  blunt ended,  Nco I linkers  (a generous gift of Dr.  R.  Gregson, 
Biotechnology Australia,  Proprietary  Ltd.,  Roseville, NSW) were added  and 
the plasmids were religated to generate a series of deleted variants of pBR9B. 
These were sequenced from the Nco I site in order to identify those carrying 
appropriate  in-frame deletions. The small Xho I/Nco I fragments containing 
modified  5'-regions  of the  gene  were  retrieved  and  incorporated  into  the 
expression vector (pJC9) by a three-way ligation as outlined in Fig. I. Another 
mutant (I-14), which deleted the first ATG and therefore the first hydropho- 
bic domain, was prepared  as  follows. Xho I linkers were added  to an Eco 
RV/Bam HI  fragment  (Figs.  1 and  2).  This  fragment  was cut with  Xho 1 
and Nco I and the smaller Xho I/Nco I fragment isolated. This segment was 
then reincorporated  into pJC9  by the three-way  ligation  method described 
above.  Mutant  2-8  was  constructed  as  follows. The  oligonucleotides  5' 
CATGGTTCTAACCTTTCTGATAT 3' and 5"CGATATCAGAAAGGTTA- 
GAAC  3'  were made  using a  DNA synthesizer  (Applied  Biosystems, Inc., 
Foster  City,  CA). These  are complementary  and  create  Nco  I- and  Cla  I- 
compatible termini when annealed. The oligonucleotides were phosphorylated 
and ligated with the EcoR1/Xho 1 fragment from pJC9 (Fig. 1  ) and a fragment 
from the same plasmid, which extended through the VP7 gene, counterclock- 
wise from the EcoR I site to the Cla I site near the 5'-end of the gene (7). The 
fourth fragment which permitted the vector to circularize was an Xho 1/Nco I 
fragment of 53 bases derived from a pBR9B deletion  mutant (Fig. 1  ), where 
the Bal 31  digestion went precisely to the first ATG codon. This construction 
deleted the first eight amino acids of VP7 which are conserved between human, 
simian, and bovine rotaviruses, and substituted Met-Ala-Met such that the final 
NH2-terminal sequence now reads as Met-Ala-Met-Val-Leu-Thr ....... 
Polyclonal Anti-VP7 Antiserum:  SAIl rotavirus was propagated 
and purified by published procedures (37). Intact double-shelled virions labeled 
with 1251 (26) were concentrated by ultracentrifugation and disrupted by boiling 
in an SDS dissociation buffer containing  2-mercaptoethanol  (25). Viral poly- 
peptides were resolved by electrophoresis on discontinuous  slab gels (25) and 
the band corresponding to VP7 located by radioautography. The region of the 
gel  containing  the  SDS-denatured  VP7  was  recovered,  homogenized  with 
incomplete Freund's adjuvant,  and injected subcutaneously into rabbits. Ani- 
mals were boosted at 4-wk intevals and the antiserum confirmed as monospe- 
cific by Western blot analysis (42). 
Cell  Growth,  Transfection, Tunicamycin  Treatment, and 
Radiolabeling:  The  RRI  strain  of Escherichia coli was  used  for  the 
propagation of all plasmid DNA used for transfections. After standard bacterial 
lysis procedures  (29), DNA was isolated  and  purified  by  cesium  chloride- 
ethidium bromide ultracentrifugation  followed by precipitation and resuspen- 
sion in water. The procedure for transfection of COS 7 cells (18) follows that 
of  published procedures (34) with several modifications. COS 7 cells were grown 
on  100-mm dishes in  Dulbecco's  modified  Eagle's medium  (DME)  (Gibco 
Laboratories,  Grand Island,  NY),  containing  5%  each of calf and fetal calf 
serum,  100 U/ml penicillin, 100 ~g/ml streptomycin (Gibco Laboratories) and 
2 mM L-glutamine. Monolayers that were 60-80% confluent were washed and 
transfected in Tris-buffered saline (19). DNA (l 5-30 ~g/ml) was added to each 
plate followed by the addition of DEAE-dextran  (Pharmacia  Fine Chemicals, 
Piscataway, NJ; 2 ×  l06 daltons; 500 ug/ml) (19). After  1.5-2 h at 37"C, the 
Tris-buffered saline  solution  was removed  and  DME,  containing  serum as 
above and  100 uM chloroquine  (Sigma Chemical Co., St.  Louis, MO), was 
added to the cells. After incubation  for 3 h at 37"C, DME without chloroquine 
but containing  serum and additions as above was added. At 45 h after DNA/ 
DEAE-dextran  removal, the cells were incubated at 37"C for l h in DME salts 
lacking serum and  methionine  but supplemented  with all other amino acids 
and l mg/ml glucose. Transfected cells were then labeled for 2.5 or 4 h at 37"C 
on a rocker platform  in the above medium to which L-[35Slmethionine at a 
concentration  of 150 uCi/ml was added. At the end of the labeling period, the 
medium was collected and non-adherent  cells were pelleted by centrifugation 
in  an  Eppendorf centrifuge  for  l0  min.  Supernatants  were  removed  and 
analyzed for expressed secreted material. 
For those cells treated with tunicamycin,  dishes were incubated in medium 
containing  tunicamycin  (Sigma Chemical Co.), at a final concentration  of 2 BomH[  xhoI  V 
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FIGURE  I  Strategy for the construction 
ofVP7 gene deletions in an SV40 expres- 
sion vector. See Materials  and Methods 
for  details.  Solid  bars are  VP7  coding 
sequences. Open bars represent  the lo- 
cation  of  VP7  hydrophobic  domains. 
Thin  lines  are  pBR322  and  SV40 se- 
quences. Stippled area corresponds to 
the 50-bp noncoding region of the VP7 
gene 5' to the ATG start codon. 
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FIGURE 2  Structure of the 5'-end of the VP7 gene showing the location of deletion mutants within it and_the  NH2-terminal 
sequence of the protein. The hydrophobic domains underlined in the amino acid sequence were identified previously (7, 9) but 
may vary if other criteria are applied. The single glycosylation site is located at residue 69. The deletions are numbered according 
to the amino acid residues actually deleted. Due to the addition of Nco I linkers in the constructions (see Materials and Methods), 
Set at position 61  is changed to Ala in all mutants numbered  N-61.  In the complete VP7 clone used  for these  studies,  two 
conservative amino acid changes occurred compared with the originally published sequence derived from an incomplete clone 
(7). C32 and L~7 are both changed to F. 
PORUCHYNSKY  IT AL.  Secretion  of an Endoplasmic Reticulum Clycoprotein  2201 #g/ml (41), beginning  at 42.5  h  after  transfection  and  continuing  for 8  h 
thereafter.  Tunicamycin  was therefore present for 4 h prior to radiolabeling, 
including  the  l-h preincubation  in medium lacking methionine,  as well as 
during the 4-h labeling period. 
Immunoprecipitation:  Cell  monolayers were rinsed in ice-cold phos- 
phate buffered saline (PBS), harvested, and lysed in buffer containing  1% each 
of deoxycholate and Triton X-100, 0.1% SDS, and 0.15 M NaCI in 25 mM 
Tris-HCl,  pH 8.0, containing  100 U/ml Traysylol. The nuclei were pelleted 
(34) after the addition  of more detergent. Standard procedures (3), with some 
modification,  were used for immunopreeipitation  of proteins  from the post- 
nuclear  supernatant  by rabbit  polyclonal antiserum to VP7 and protein  A- 
conjugated  Sepharose C1AB (PAS) (Pharmacia  Fine Chemicals). Beads were 
swollen in distilled water and added to transfected cell lysates before incubation 
with antibody.  PAS beads were pelleted by centrifugation  and discarded (12) 
in an attempt to eliminate  any nonspecifically adherent  proteins.  Polyclonal 
anti-VP7  serum  was then  added  to  lysates  which  were  incubated  at  4"C 
overnight before the addition  of PAS beads. These had been preincubated  for 
several hours in a solution containing  10 mg/ml bovine serum albumin and a 
postnuclear cell lysate of unlabeled, untransfected COS 7 cells. 
Medium from the transfected cell cultures had an equal volume of 2x lysis 
buffer added which contained  1 mM methionine  and 1 mg/ml bovine serum 
albumin.  Rabbit polyclonal anti-VP7 antiserum was added to each and incu- 
bated overnight at 4"C, followed by the addition  of pre-absorbed PAS beads. 
In an effort to reduce background bands from the media in other experiments, 
such as that examining the effect of tunieamycin,  PAS beads were additionally 
pre-absorbed with media from COS 7 cell cultures. Beads were pelleted from 
all samples and washed extensively in buffers containing detergent and then in 
PBS (3). After boiling the beads in 0.05 M Tris-HC1, pH 6.7, containing  1% 
SDS (34) to remove  the  bound antibody-protein complexes, 0.2  M  citrate- 
phosphate buffer, pH 5.0, was added prior to treatment  of half of each sample 
with  0.041  U  of endo-fl-N-acetylglucosaminidase  H  (endo-H)  prepared  as 
described (39), at 37"C for 1 h. A lysate of L-[35S]methionine-labeled SA1 l- 
infected MA 104 cells was prepared and treated with endo-H for use as a marker. 
The reactions were stopped by addition of buffer containing  100 mM Tris, 5% 
SDS,  1 mM EDTA, 50 mM dithiothreitol,  10% glycerol, 0.1% bromophenol 
blue,  100 ug/ml soybean  trypsin  inhibitor,  200  U/ml Traysylol,  5  mM 8- 
aminocaproic  acid,  1 mM  benzamidine,  and  2  mM  phenylmethylsulfonyl 
fluoride. Samples were boiled for 3 min and analyzed by SDS PAGE on 12% 
gels (25) run at constant  voltage. Gels were fixed, fluorographed  in Amplify 
(Amersham Corp., Arlington Heights, IL) for 20 min, dried, and then autora- 
diographed  at -70"C using Kodak  SB 5 film. Composites of photographs  of 
gels were always assembled from equivalent or identical exposures with com- 
parable markers. 
Immunofluorescent  Localization and  Electron Micros- 
copy:  COS  7  cells which  had  been  grown  to  semi-confluency  on glass 
coverslips (Coming Glass Works, Coming, NY), in 35-ram dishes, were trans- 
feLLed in Tris-buffered saline as described above, washed with chloroquine  for 
3 h, and incubated  with  DME containing  serum.  At  47  h after removal  of 
DNA/DEAE-dextran, cells were washed in PBS and fixed for 45 min at 22"C 
in 2% formaldehyde, freshly prepared from paraformaldehyde, and then buff- 
ered in 0.05 M phosphate,  pH 7.5. The coverslips were rinsed in PBS for 20 
rain, then soaked in  I% Triton X-100 in PBS for 20 rain to permeabilize the 
cells. After two 10-rain rinses in PBS, the coverslips were incubated for 1 h at 
37"C in a solution containing polyclonal rabbit anti-VP7 diluted  1:400 in PBS 
and rbodamine conjugated to wheat germ agglutinin (R-WGA) (Vector Labo- 
ratories,  Inc., Burlingame, CA) diluted  1:300 or  1:400. The cells were then 
rinsed exhaustively in PBS and incubated in a 1:300 dilution of  secondary goat 
anti-rabbit  IgG conjugated to fluoreseein (Cappel Laboratories, Cochranville, 
PA) for 45 min at 37°(L Cells were photographed  in the same plane of focus, 
with a Zeiss Ili RS photomicroscope,  using appropriate  filters for fluorescein 
or rhodamine. 
To examine  the  ultrastructural  morphology  of untreated  COS 7- and of 
SA1 l-infected  MA104 cells (5.5 h post-infection,  infected according to pub- 
lished methods [12]), coverslips were fixed in 2%  glutataldehyde  in 0.1  M 
cacodylate  buffer, pH 7.4, for 45  min at 22"C. Cells were postfixed in  1% 
osmium tetroxide in cacodylate buffer, stained in 1% uranyl acetate, dehydrated 
in ethanol, and embedded in resin before thin sectioning. Sections were stained 
with uranyl rinse and Reynolds lead stain  for several minutes (33) and then 
specimens  were  examined  and  photographed  in  a  JEOL  100  CX  electron 
microscope at 80 kV. 
RESULTS 
Morphogenesis of Rotavirus Particles  in SA 11- 
infected/VIA 104 Cells 
One novel feature of the rotavirus system is that the virus 
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appears  to be located primarily in elements  of the ER (1). 
However, these earlier  studies also showed that at  16-24 h 
post-infection, virus was sporadically present in other cellular 
organelles in cells showing extensive damage.  We have ex- 
amined  the distribution of virus particles  in  cells  early in 
infection. At 5.5 h post-infection, virus particles  were found 
only in the ER (Fig.  3);  none were ever seen in the Golgi 
apparatus or in mitochondria. The viroplasm structures  im- 
mediately adjacent to the RER were also evident and viral 
cores could be seen budding from the periphery of the viro- 
plasm  into the lumen of the RER.  The  envelope acquired 
from  the RER  membrane  was  subsequently lost and both 
enveloped and  mature  virions were  visible  in the lumenal 
space (Fig. 3). VP7 has been located to the ER by immunoe- 
lectron microscopy (10, 32). In vitro translation studies have 
also shown it to be an integral membrane protein (2 I). Since 
the VP7 protein is found in mature virions and has only high- 
mannose oligosaccharides (9), the data collectively show that 
VP7 remains in the ER after translation. However, the mech- 
anism by which VP7 is incorporated into the virus remains 
unknown. Thus, the rotavirus VP7 provides an opportunity 
to  study the factors  controlling the specific  localization of 
proteins to the ER. 
Ultrastructural  Morphology of COS 7 Cells 
To accurately interpret the localization of expressed VP7 
protein  products  within  COS  7  cells,  it  was  necessary  to 
examine  the  ultrastructural  morphology and  interrelation- 
ships of organelles in COS 7 cells, especially in the perinuclear 
region.  These  cells  are  characterized at  their periphery by 
predominantly free polysomes crowding the cytoplasm and 
by numerous microvilli projecting from their cell surface (Fig. 
4). The cells are often multinucleate, have many lipid droplets, 
mitochondria,  and  a  preponderance  of organelles  situated 
close to each other around the nucleus at the center of the 
cell (Fig.  4, a and b). The perinuclear region is occupied by 
extensive branching ER, which contains numerous areas  of 
transitional elements (Fig.  4 and inset) and smooth ER that 
spatially intertwine with, but are distinct from, the extensive 
perinuclear Golgi apparatus.  It is evident that portions of the 
Golgi apparatus can surround concentrated elements of the 
ER. 
Immunofluorescent Localization  of VP7 Proteins 
in Transfected COS 7 Cells 
The gene encoding the VP7 protein was inserted into the 
vector pJC119 under the control of the SV40 late promoter 
to generate the plasmid pJC9 (as described in the Materials 
and Methods). The expression of the VP7 protein from this 
gene was examined in transfected COS 7 cells to confirm the 
ER location of this protein. An indirect immunofluorescent 
procedure using a  secondary fluorescein-coupled goat anti- 
rabbit Ig and a primary monospecific polyclonal rabbit anti. 
serum  was used to localize VP7.  A  concomitant display of 
WGA,  conjugated to rbodamine (R-WGA),  and known to 
specifically bind to sialic acid and terminal glucosamines in 
the Golgi apparatus (40), allowed us to determine if VP7 was 
present in this  organelle.  The  immunolocalizafion  of VP7 
expressed  from pJC9  shows a distinct, arborizing, reticular 
pattern of fluorescein staining radiating from the nucleus, and 
a perinuclear concentration of stained, reticular material (Fig. FIGURE  3  Morphology of SA11 rotavirus- 
infected MA104  cell at  5.5  h  post-infec- 
tion.  Infected  cells  show  spherical viro- 
plasm  (V)  structures  in  the  cytoplasm. 
These are composed of several viral pro- 
teins and nucleic acid which assemble into 
viral cores (arrows) that bud from the pe- 
riphery of  the  viroplasm into the  rough 
endoplasmic  reticulum  (RER).  Immature 
viral particles with surrounding ER  mem- 
brane appear in the lumen of the ER (large 
black arrowheads), as do numerous, non- 
enveloped,  mature  forms  of  the  virion 
which  are  devoid  of  membrane  (small 
black arrowheads). Several viral particles 
are indicated which apparently are in the 
process  of losing the  surrounding mem- 
brane (white arrowheads); possible mem- 
brane remnants can also be seen (m). M, 
mitochondrion, x  41,500. 
5). This probably corresponds to the RER and to transitional 
elements of ER, spatially related to, but exclusive of, the Golgi 
apparatus  (see Fig.  4b and  inset).  Nuclear staining  is  also 
evident. Fig.  5 b shows the same cell stained with R-WGA. A 
staining pattern consisting of punctate material and a  peri- 
nuclear  localization,  probably coincident  with  part  of the 
Golgi apparatus and distinct from that of  the VP7 localization, 
is seen. Thus, VP7 protein expressed from the wild-type gene 
in pJC9 appears to localize to the ER and does not appear to 
reach the Golgi apparatus. 
A series of plasmids containing mutations in the VP7 gene 
has  also  been  constructed  (see Fig.  2).  The deletions  were 
constructed  in  order to  study the  role of the  hydrophobic 
domains in  VP7  synthesis.  The location  of VP7  expressed 
from these plasmids in  COS  7  cells was also examined by 
immunofluorescence.  The  deletion  mutant  1-14  displayed 
extensive ER and perinuclear staining in regions distinct from 
that seen for R-WGA (Fig.  5,  c and d), similar to the wild- 
type. In this mutant, the first ATG codon was deleted so that 
only the second initiation codon and the hydrophobic region 
following it could be used (Fig.  2). Another mutant studied, 
2-8,  in which the  sequence  following the first ATG codon 
was modified (see  Materials  and  Methods),  showed results 
analogous to the wild-type (Fig.  5, e and f). In contrast, VP7 
distribution  in  the  mutants  42-61,  43-61,  and  47-61,  in 
which  distal parts of the  second hydrophobic domain were 
removed (Fig.  2),  showed  reticular  staining  and  a  distinct 
perinuclear distribution  which  coincided  precisely with,  or 
was a  subset of, the  R-WGA staining pattern (Fig.  5,  g-l). 
Thus it appeared that with these deletions, the mutant VP7 
proteins reached the Golgi apparatus. Mutant  51-61, whose 
deletion removed a region distal to the hydrophobic domains, 
exhibited a staining pattern identical to the wild-type, that of 
reticular staining and a perinuclear distribution distinct from 
that  of the  R-WGA  staining  pattern.  It  appears  that  the 
absence of the region coding for these amino acids was not 
sufficient to cause movement of VP7  out of the ER to the 
Golgi apparatus. 
Intracellular Expression of VP7 Proteins 
To confirm and extend the above results, we also examined 
VP7 expression from wild-type and mutant genes by immu- 
noprecipitating  radiolabeled  proteins  from cell  lysates (see 
Materials and Methods). Cells were transfected with plasmids 
containing the wild-type gene (pJC9) or deletions  1-14, 2-8, 
42-61,  43-6 l, 47-6 l, or 51-61  (Fig.  2).  VP7 proteins were 
immunoprecipitated and displayed by gel electrophoresis be- 
fore or after digestion  with  endo-H and  compared on  the 
same gel alongside L-[35S]methionine-labeled SAI l-infected 
MA104  cell lysate. No significant products were seen when 
either no DNA (Fig.  6) or the vector pJC119 was used as a 
control (see below, Fig. 8). However, the wild-type and mutant 
genes all  expressed a  protein(s) precipitable with  anti-VP7 
antiserum (Fig. 6, -  lanes). In the case of the intact VP7 gene 
(pJC9) and the deletion  1-14, two products were seen in the 
absence of endo-H, but the lower band was relatively minor, 
not  always  reproducible,  and  its  origin  is  uncertain.  For 
mutants 42-61 and 51-6 l, two products were expressed and 
it is very likely that the lower molecular weight species was 
the  nonglycosylated version of each protein.  In the case of 
mutant 51-61, it is possible that the lower molecular weight 
band arises from use of the third in-frame AUG as a  start 
PORUCHYNSKY ET AI..  Secretion  of an Endoplasmic  Reticulum Glycoprotein  2203 FIGURE 4  Morphology of peripheral and central regions of COS 7 cells. (a) The peripheral region of the cell is heavily populated 
with free polysomes.  Mitochondria (m), lipid droplets (L), and portions of the rough endoplasmic reticulum (RER) extend into this 
region.  The central regions of the cell are more densely populated with ER, transitional and smooth elements  of ER. x  13,500. (b 
and inset) The perinuclear region of the COS 7 cell is typically characterized  by an extensive Golgi apparatus.  Its several stacks 
(arrows) are surrounded by extensive endoplasmic reticulum (ER) which exhibit ribosome-studded, transitional (TE), and smooth 
elements that spatially intertwine with, but are distinct from,  the Golgi apparatus.  N, nucleus; m, mitochondria, x  17,820. (Inset, 
20,250.) 
2204  THE  JOURNAL OF  CELL BIOLOGY • VOLUME  101,  1985 FIGURE  5  The  immunofluorescent  localiza- 
tion of VP7 (left column) compared with that of 
R-WGA  (right  column)  in  transfected  COS  7 
cells.  Fluorescein  coupled  to  goat anti-rabbit 
IgG  was  used  secondary  to  primary  rabbit 
polyclonal  antiserum  to  immunolocalize VP7. 
All pairs were photographed in the same plane 
of focus. Cells transfected with pJC9 (a and b); 
mutants 1-14 (c and d); 2-8 (e and/); 42-61  (g 
and h); 43-61  (i and j); 47-61  (k and/); or 51- 
61  (m and n). VP7 is localized to an arborizing 
structure probably corresponding to ER, as well 
as to a perinuclear reticular structure, possibly 
transitional  ER  elements,  which  are  distinct 
from but close to that of the perinuclear punc- 
tate stain for WGA and the Golgi apparatus as 
displayed in a-f, and m and n. In some cases, a 
negative image of the staining region of VP7 is 
seen for WGA (c and d). By contrast, the three 
deletions shown in g-I not only exhibit the ER 
reticular localization for VP7, but also a promi- 
nent perinuclear staining region that is precisely 
coincident  with,  or  a  subset  of,  the  staining 
pattern for WGA.  ×  126. 
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intraceltular  products  of  cells 
transfected  with  full-length  and 
mutated VP7  genes. Cells  were 
labeled for 4 h with t-[~SS]methi  - 
onine, as  described  in  the text, 
the VP7 proteins  immunoprecip- 
itated  (-  lanes), and  half of the 
samples digested with endo-H (+ 
lanes) (see Materials  and  Meth- 
ods). Total SA11-infected MA104 
cell lysate before (-:) and after (+) 
Endo-H  is shown as a marker to 
indicate the position of the gly- 
cosylated  (VP7) and  digested 
(pVP7) versions of VP7. 
codon. This possibility is made less likely because for mutant 
42-6l  a  similar  unglycosylated  band  of the  same  size  is 
secreted, implying the use of a functional signal which would 
not be translated if the third AUG was used as an initiation 
codon.  The  wild-type and  mutant  genes  each  expressed a 
product  which  was  sensitive  to  endo-H  (Fig.  6,  +  lanes), 
indicating that they were glycosylated with  N-linked,  high- 
mannose oligosaccharides. There was no significant intracel- 
lular pool of VP7 products that were resistant to endo-H (Fig. 
6). Cells were transfected and then incubated in the presence 
or absence of tunicamycin and the resulting unglycosylated 
products were slightly smaller in size than those treated with 
endo-H (data not shown), again indicating the N-linked na- 
ture of  the oligosaccharide. Taken together, these results imply 
that each mutant codes for proteins which retain a functional 
signal for translocation into the ER. For the  1-14 deletion, 
where  only the  second ATG and  hydrophobic domain are 
retained,  the  latter probably constitutes the  signal  peptide. 
For the wild-type and other mutants, the translocation signal 
domain  cannot  be  specified  since  both  ATG  codons  and 
hydrophobic regions are present. Transfected cells labeled for 
2.5  h  showed an overall similar pattern of expression of the 
intracellular VP7 products, and again there was little evidence 
of intracellular material resistant to endo-H (data not shown). 
Extracellular Products Expressed by VP7 Genes 
Immunofluorescence studies indicated that for mutants 42- 
61, 43-61, and 47-6 l, VP7 staining co-localized with that of 
elements of the Golgi apparatus in  COS  7  cells,  indicating 
that these VP7 mutants were probably transported out of the 
ER. Therefore, the incubation media from all the transfected 
cell cultures described above were examined for secreted VP7 
products. Three of the deletion mutants, 42-61, 43-6 l, and 
47-61, affecting the distal region of the second hydrophobic 
domain produced VP7 molecules which were secreted (Fig. 
7), in marked contrast to the behavior of the wild-type VP7 
(pJC9), and the other mutants (51-61  in particular) (Fig.  7). 
The latter differed by only four amino acids from the secreted 
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mutant 47-61 (Fig. 2). In addition, the secreted VP7 products 
were endo-H resistant (Fig.  7, +  lanes), consistent with their 
passage through the Golgi apparatus and their modification 
to the complex type of carbohydrate. Densitometry of respec- 
tive bands of original autoradiographs used for Figs. 6 and 7, 
which  were  equivalently  exposed,  showed  that  similar 
amounts of  secreted and intracellular VP7 were present. These 
results pertain to cells labeled for 4 h. However, similar results 
were obtained in a  2.5-h  labeling period (data not  shown), 
indicating that  secretion is an efficient process. The size of 
the  VP7  which  contained  complex oligosaccharides (VP7  c) 
was slightly larger than that of VP7 with the high-mannose 
form of glycosylation (VP7) (Fig. 8, lanes 5 and 7) as expected 
from the known higher molecular weight of  complex N-linked 
oligosaccharides.  Mutant  42-61  also  secretes,  based  on  its 
size, a nonglycosylated version of its mutant VP7 protein (Fig. 
7). This was confirmed by another experiment where cultures 
transfected with mutants 42-6 l, 43-6 l, or 47-61  were sub- 
sequently treated  with tunicamycin (Fig.  8,  mutant  43-6 l 
only shown). The product generated in the presence of tuni- 
camycin (Fig.  8,  +  lanes) (VP7 u)  is identical in  size  to the 
naturally occurring unglycosylated product of mutant 42-6 l 
(Fig.  7). Some material the size of VP7 remained after tuni- 
camycin treatment (Fig. 8, lane 8) probably because of limit- 
ing amounts of the drug, since in other experiments tunica- 
mycin resulted in complete conversion to VP7  u.  In control 
cells, those not treated with tunicamycin (Fig.  8, lane 5), the 
endo-H-resistant product  was again  secreted  into  the  me- 
dium. Similar results were obtained with mutants 42-61 and 
47-61  (data not shown). The amount of protein secreted in 
tunicamycin-treated cells (Fig.  8, lane 6) was lower than that 
of the control, possibly because the drug interferes with secre- 
tion. No such bands were identified when the vector (pJC 119), 
without VP7  gene insert,  was used for transfection (Fig.  8, 
lanes  1-4).  The  presence  of prominent  nonspecific  back- 
ground  bands  (Fig.  8,  lanes  1,  2,  4,  and  6-8),  which  are 
different for the intracellular (intra)  and secreted (sec) lanes, 
does not alter this conclusion. These results confirm that the FIGURE 7  Endo-H  sensitivity  of 
immunoprecipitated  products 
from  the  media  of  cells  trans- 
fected  with  wild-type  and  mu- 
tated VP7 genes. Cells  were  la- 
beled for 4 h with L-[3SS]methio  - 
nine as  described,  the  medium 
from  each  culture  subjected  to 
immunoprecipitation  (-  lanes), 
and  half of the samples digested 
with  endo-H  (+  lanes). Total 
SA11-infected  MA104 cell lysate 
before (-)  and  after (+)  Endo-H 
displays  marker  glycosylated 
(VP7) and  digested  (pVP7) pro- 
teins.  The length of exposure of 
this gel was equivalent to that of 
Fig. 6. 
endo-H-resistant products secreted into the medium by these 
mutants contain an N-linked complex type of carbohydrate. 
Secreted  VP7  c was again  observed to  be  endo-H-resistant 
(data not shown) and to be present in approximately the same 
amount as the internal endo-H-sensitive VP7 (Fig. 8, lanes 5 
and 7). 
FIGURE 8  Secretion  of mutant VP7  proteins in the  presence  of 
tunicamycin. Cells transfected  with pJC119 (lanes I-4}; or mutant 
43-61  (lanes 5-8),  were labeled with  t-[35S]methionine  for 4  h. 
Where indicated (+), tunicamycin (2 ~g/ml) was added for the last 
8 h of transfection; (-) are untreated cells. VP7  u refers to unglyco- 
sylated VP7 proteins,  and VP7  c corresponds  to VP7 with complex 
DISCUSSION 
In  order  to  understand  the  specificity  in  the  location  of 
membrane glycoproteins, we have used a glycoprotein that is 
located in  the  ER  in  its natural  state.  ER location  implies 
either the presence of a targeting signal specific for the ER or 
the absence of a  positive signal that would otherwise direct 
the protein elsewhere. The structural glycoprotein VP7, of the 
rotavirus SA11,  provides just such  a  naturally targeted ER 
protein. It is a membrane glycoprotein (21) before assembly 
into virus. How the transfer of the glycoprotein takes place is 
not  known  and  we know of no  other  animal virus which 
exhibits  this  behavior.  However,  the  mode  of transfer  of 
membrane protein to the virus particle resembles the assembly 
of coat protein into the filamentous phage M 13 (44). 
Analysis of the amino acid sequence of VP7 has shown the 
existence of two tandem NH2-terminal hydrophobic domains, 
within the first 50 amino acids. Each is preceded by an in- 
frame ATG codon.  Since the  first ATG is "weak" and the 
second one has the preferred consensus sequence for initiation 
(24),  we cannot be sure which one is used for VP7 synthesis, 
and  are  unable  to  say  where  the  reported  signal  peptide 
cleavage occurs (13).  Since mutant  1-14, which deletes the 
first ATG codon, still produces a glycoprotein located in the 
ER, the second hydrophobic domain can provide signal pep- 
PORUCHYNSKY  lET  AL. 
carbohydrate.  The positions  of migration in this gel of VP2 (94k), 
VP7 (38k)  (with high-mannose carbohydrate),  and NCVP5 (29k) in 
infected cell lysates are shown. 
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important in the maturation of rotaviruses since the hydro- 
phobic nature is highly conserved in the VP7 glycoproteins 
of viruses infecting human, simian, and bovine species (20), 
and therefore probably serve some role in anchoring this type 
of  protein in the ER. There is no hydrophobic segment present 
at the COOH-terminus, a distinctive feature of the glycopro- 
teins of plasma membrane maturing viruses. Our systematic 
generation of mutants affecting each or both of the hydropho- 
bic regions was aimed at identifying the putative membrane 
anchor domain responsible for the ER location of the rotavi- 
rus VP7 glycoprotein. 
The key observation is that in three of the deletion mutants 
extending into the second hydrophobic region, namely mu- 
tants 42-61,  43-61,  and 47-61, the altered form of VP7 is 
secreted by transfected COS 7 cells and terminally glycosy- 
lated, a characteristic of a protein having traversed the normal 
secretory pathway.  By contrast,  neither  the  wild-type gene 
product was secreted, nor were products from deletions which 
affected other parts of  the molecule. The deletion 1-14, which 
completely removed the first hydrophobic domain and mu- 
tant  2-8,  in which  the eight  amino terminal residues con- 
served in all four rotavirus VP7 serotypes (9) were changed 
(see Materials and Methods), efficiently expressed glycopro- 
tein located to the ER. Similarly, removal of only 11  amino 
acids downstream of the hydrophobic domains in mutant 51- 
6 l, apparently was not sufficient to influence the movement 
of VP7 from the ER to the Golgi apparatus. The only effect 
was to  perturb  the  efficiency of glycosylation, perhaps for 
steric reasons, since the glycosylation site in the altered prod- 
ucts is brought closer to the hydrophobic domains. 
The carbohydrate present on VP7 is of the high-mannose 
type and is endo-H sensitive, consistent with its ER location 
and the absence of terminal processing of the oligosaccharide. 
Analysis of VP7 glycoprotein processing shows that it does 
not  reach the Golgi apparatus but rather accumulates in  a 
subcompartment of the  ER in  a  processing pathway quite 
different from VSV G-protein (21).  In our current observa- 
tions, it should be noted that there is a distinctly larger size 
of the secreted VP7s in mutants 47-61, 43-61,  and 42-61, 
due to the terminal glycosylation; they are also sensitive to 
tunicamycin and resistant to endo-H. This observation un- 
derscores the ER location of wild-type VP7 since it is apparent 
that its N-linked glycosylation can be modified and were the 
wild-type  molecule  to  have  reached  the  Golgi  apparatus, 
further  processing  and  terminal  glycosylation should  have 
occurred.  In  the  mutant  VP7s,  the  efficiency of secretion 
appears to be high for two reasons. First, there is no endo-H- 
resistant  material inside  the  cell  after either 2.5  or 4  h  of 
labeling. Second, the amount of material secreted is similar 
in amount to that seen intracellulady. 
Other glycoproteins of the ER have been cloned and some 
sequenced.  In  the  cases  of HMG-CoA  reductase  (27)  and 
coronavirus E 1 (4), there was no obvious homology between 
the NH2-terminal hydrophobic domains in these molecules 
and VP7,  nor with the dual NH2-terminal hydrophobic do- 
mains in  nonstructural  rotavirus glycoprotein NCVP5  (8). 
Cytochrome P-450 (31), another ER protein, did not display 
any obvious homologies in its multiple hydrophobic domains. 
It should  be  noted,  however,  that  3-hydroxy-3-methylglu- 
taryl-CoA reductase, coronavirus El, and cytochrome P-450 
probably interact with the lipid bilayer much more extensively 
than does VP7, via multiple membrane spanning domains. 
2208  THE  JOURNAL  OE  CELL  BIOLOGY .  VOLUME  101,  1985 
Since VP7 is not normally secreted, presumably there could 
be no specific ER receptor (14,  28) mediating its secretion, 
and therefore its movement along the secretory pathway in 
these cells is constitutive, rather than specific. This is the first 
demonstration of  an alteration in the primary sequence which 
allows a  naturally targeted ER molecule to be secreted, and 
shows unequivocally that glycoproteins can be secreted with- 
out the intervention of a specific receptor. Also of significance 
is that an unglycosylated, mutant VP7 is efficiently secreted. 
The precise reason(s) for the secretion of VP7 in the mutants 
42-61, 43-61, and 47-61 is not yet clear. It could be that an 
anchor region has been shortened so that it no longer func- 
tions, that a positive signal for ER location has been disrupted, 
or that a peptidase cleavage site, e.g., the Ala-Tyr-Ala  sequence 
at residues 66-68  (43),  has been brought into proximity of 
the aminopeptidase used for signal peptide cleavage. These 
possibilities are being investigated. Our results become partic- 
ularly interesting when juxtaposed with several other obser- 
vations. Firstly, some normally soluble molecules of the ER 
(2,  5)  remain in  the  ER,  whereas soluble VP7  is secreted. 
Secondly, influenza neuraminidase is anchored in the mem- 
brane  by  an  NH2-terminal  hydrophobic  domain,  but  this 
molecule, unlike VP7, is exported to the plasma membrane 
(6). From the above, we conclude that the region of  the second 
hydrophobic domain of VP7  not only serves to anchor the 
protein in the membrane but may also contain the positive 
and specific signal for maintaining the protein in the ER. 
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Note Added  in  Proof.  VP7  antigens secreted by COS  7 cells 
transfected with mutants 42-61, 43-61, or 47-61 were immunopre- 
cipitable by polyclonal antiserum raised against intact SAIl  virus 
illustrating that at least some epitopes on these molecules were in a 
native configuration. 
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